Company Profile Company Profile and History

Corporate Movie

Basic Information

Trade nameFuso Pharmaceutical Industries,Ltd.
Head Office1-7-10, Doshomachi, Chuo-ku, Osaka, Japan
EstablishedMarch 25, 1937
PresidentMikio Toda
Capital10 billion 758 million yen
Financial monthMarch
Correspondent banksSumitomo Mitsui Banking Corporation, Sumitomo Mitsui Trust Bank, Limited, MUFG Bank, Ltd., Resona Bank, Limited
Stock exchangePrime Market of Tokyo Stock Exchange(Securities Code 4538)
Number of employees1,307 (As of March 31, 2024)
Principal lines of businessResearch and development, manufacturing and sale of pharmaceutical products


1937March Established, Minami-ku, Osaka (currently Higashisinsaibashi, Chuo-ku, Osaka) under the trade name of Yamato Shokai, Ltd. in Unagidani, with the main business of selling domestic glucose.
1942December With time, glucose became centrally rationed and controlled, and the company planned to shift to manufacturing injections made from glucose. Subsequently, its trade name was changed to Fuso Sangyo, Ltd.
1943June Established Imazato Factory in Higashinari-ku, Osaka, and started manufacturing and marketing injectables such as glucose injections, Ringer’s solution, and Isotonic sodium chloride solution, formally entered the pharmaceutical manufacturing industry.
1949March Changed its trade name to Fuso Pharmaceutical Industries, Ltd.
1953July Moved the main office to Higashi-ku, Osaka (currently Chuo-ku, Osaka).
1957March Established Joto Factory in Morinomiya, Joto-ku, Osaka, and closed the Imazato Factory.
1963November Launched "Haemolind," Japan’s first sublingual tablet for hemorrhoids, and expanded into manufacturing OTC drugs.
1964April Established Kyobashi Factory in Shinkita-cho, Joto-ku, Osaka. Expanded and strengthened the field of internal drugs such as tablets and capsules.
1964August Developed and began supplying the hemodialysis solution Fuso as the first dialysate in Japan.
1970October Listed on the Second Section of the Osaka Stock Exchange. Established Fuso Kohatsu, Ltd. as a subsidiary.
1973February Culture and Sports Center, "Fuso Kaikan," was constructed in Joto-ku, Osaka (near Kyobashi Station). The management was entrusted to Fuso Kohatsu, Ltd.
1979November Established Daito Factory in Hiranoya Shinmachi, Daito City. Started operations as an internal drug production factory and closed the Kyobashi Factory.
1981April Constructed Research and Development Center on the north side of the Joto Factory.
1983September Listed on the First Section of the Osaka Stock Exchange.
1985May Constructed Okayama Factory in Satosho-cho, Asakuchi-gun, Okayama Prefecture.
1989December Listed on the First Section of the Tokyo Stock Exchange.
1994April Constructed "Fuso Doshomachi Building" at the Main Office location.
1995May Constructed Ibaraki Factory in Kitaibaraki City, Ibaraki Prefecture.
2000December Entered the field of assisted reproductive technology with the launch of "HFF99," a culture medium for in vitro fertilization and embryo culture.
2001January Constructed "Fuso Nihonbashi Building" in Honmachi, Nihombashi, Chuo-ku, Tokyo.
2007January Discontinued the sports business (bowling, etc.) of Fuso Kouhatsu, Ltd.
2013March Completed liquidation of Fuso Kouhatsu, Ltd.
2016April Established the second formulation building at the Ibaraki Factory and started in-house production of powder dialysate for hemodialysis.
2022April Moved from the First Section of the Tokyo Stock Exchange to the Prime Market.
2024February Expanded and began production of powder dialysate for hemodialysis in the second formulation building at the Ibaraki Factory
Net sales
Sales Composition Ratio (Data for FY2023)